Prudential Financial’s Day One Biopharmaceuticals DAWN Stock Holding History

Prudential Financial’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,260	Closed	-$263K	–	2510
2026 Q1	$263K	Buy	+12,260	New	+$173K	﹤0.01%	2059
2025 Q3	–	Sell	-10,682	Closed	-$69.4K	–	2450
2025 Q2	$69.4K	Buy	+10,682	New	+$73.5K	﹤0.01%	2316
2024 Q3	–	Sell	-22,592	Closed	-$311K	–	2728
2024 Q2	$311K	Sell	22,592 -146,930	-87%	-$2.15M	﹤0.01%	2338
2024 Q1	$2.8M	Buy	+169,522	New	+$2.54M	﹤0.01%	1249
2022 Q4	–	Sell	-38,315	Closed	-$767K	–	2609
2022 Q3	$767K	Buy	+38,315	New	+$815K	﹤0.01%	1880
2022 Q1	–	Sell	-13,935	Closed	-$235K	–	2624
2021 Q4	$235K	Buy	+13,935	New	+$286K	﹤0.01%	2488

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Prudential Financial's DAWN Position: Q2 2026 in Review

Prudential Financial sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 12,260 shares — an estimated $263K sold.

Prudential Financial first reported a position in DAWN in Q4 2021 and held it in 6 quarters. The position peaked at $2.8M in Q1 2024. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Prudential Financial reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Prudential Financial sold 12,260 Day One Biopharmaceuticals shares in Q2 2026, an estimated $263K.
Prudential Financial first reported a position in Day One Biopharmaceuticals in Q4 2021 and held it in 6 quarters.
Prudential Financial's Day One Biopharmaceuticals position peaked at $2.8M in Q1 2024.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.